Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 1289

1.

Breast cancer screening: a summary of the evidence for the U.S. Preventive Services Task Force.

Humphrey LL, Helfand M, Chan BK, Woolf SH.

Ann Intern Med. 2002 Sep 3;137(5 Part 1):347-60.

PMID:
12204020
2.

Summaries for patients. Screening for breast cancer: recommendations from the U.S. Preventive Services Task Force.

[No authors listed]

Ann Intern Med. 2002 Sep 3;137(5 Part 1):I47. No abstract available.

PMID:
12204048
3.

Screening mammography in women 40 to 49 years of age: a systematic review for the American College of Physicians.

Armstrong K, Moye E, Williams S, Berlin JA, Reynolds EE.

Ann Intern Med. 2007 Apr 3;146(7):516-26. Review.

PMID:
17404354
4.

Report of the International Workshop on Screening for Breast Cancer.

Fletcher SW, Black W, Harris R, Rimer BK, Shapiro S.

J Natl Cancer Inst. 1993 Oct 20;85(20):1644-56.

PMID:
8105098
5.

Quantitative interpretation of age-specific mortality reductions from the Swedish breast cancer-screening trials.

de Koning HJ, Boer R, Warmerdam PG, Beemsterboer PM, van der Maas PJ.

J Natl Cancer Inst. 1995 Aug 16;87(16):1217-23.

PMID:
7563167
6.

The cost-effectiveness of screening mammography beyond age 65 years: a systematic review for the U.S. Preventive Services Task Force.

Mandelblatt J, Saha S, Teutsch S, Hoerger T, Siu AL, Atkins D, Klein J, Helfand M; Cost Work Group of the U.S. Preventive Services Task Force.

Ann Intern Med. 2003 Nov 18;139(10):835-42. Review.

PMID:
14623621
7.

Screening for Breast Cancer [Internet].

Humphrey L, Chan BKS, Detlefsen S, Helfand M.

Rockville (MD): Agency for Healthcare Research and Quality (US); 2002 Aug.

8.

Screening for chlamydial infection.

Nelson HD, Helfand M.

Am J Prev Med. 2001 Apr;20(3 Suppl):95-107. Review.

PMID:
11306238
9.

Mammographic screening of women aged 40 to 49 years. Is it justified?

Feig SA.

Obstet Gynecol Clin North Am. 1994 Dec;21(4):587-606. Review.

PMID:
7731636
10.

Benefits and harms of prostate-specific antigen screening for prostate cancer: an evidence update for the U.S. Preventive Services Task Force.

Lin K, Lipsitz R, Miller T, Janakiraman S; U.S. Preventive Services Task Force.

Ann Intern Med. 2008 Aug 5;149(3):192-9. Review.

PMID:
18678846
11.

Screening mammography for women aged 40 to 49 years at average risk for breast cancer: an evidence-based analysis.

Health Quality Ontario.

Ont Health Technol Assess Ser. 2007;7(1):1-32. Epub 2007 Jan 1.

12.

Screening older adults for impaired visual acuity: a review of the evidence for the U.S. Preventive Services Task Force.

Chou R, Dana T, Bougatsos C.

Ann Intern Med. 2009 Jul 7;151(1):44-58, W11-20. Review.

PMID:
19581646
13.

Screening for skin cancer.

Helfand M, Mahon SM, Eden KB, Frame PS, Orleans CT.

Am J Prev Med. 2001 Apr;20(3 Suppl):47-58. Review.

PMID:
11306232
15.

Screening for skin cancer: an update of the evidence for the U.S. Preventive Services Task Force.

Wolff T, Tai E, Miller T.

Ann Intern Med. 2009 Feb 3;150(3):194-8. Review.

PMID:
19189909
16.

Perceptions of breast cancer risk and screening effectiveness in women younger than 50 years of age.

Black WC, Nease RF Jr, Tosteson AN.

J Natl Cancer Inst. 1995 May 17;87(10):720-31.

PMID:
7563149
17.

Screening for colorectal cancer in adults at average risk: a summary of the evidence for the U.S. Preventive Services Task Force.

Pignone M, Rich M, Teutsch SM, Berg AO, Lohr KN.

Ann Intern Med. 2002 Jul 16;137(2):132-41. Review.

PMID:
12118972
18.

Screening and prevention of breast cancer in primary care.

Tice JA, Kerlikowske K.

Prim Care. 2009 Sep;36(3):533-58. doi: 10.1016/j.pop.2009.04.003.

PMID:
19616154
19.

Screening for breast cancer: an update for the U.S. Preventive Services Task Force.

Nelson HD, Tyne K, Naik A, Bougatsos C, Chan BK, Humphrey L; U.S. Preventive Services Task Force.

Ann Intern Med. 2009 Nov 17;151(10):727-37, W237-42. doi: 10.7326/0003-4819-151-10-200911170-00009. Review.

20.

Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility: systematic evidence review for the U.S. Preventive Services Task Force.

Nelson HD, Huffman LH, Fu R, Harris EL; U.S. Preventive Services Task Force.

Ann Intern Med. 2005 Sep 6;143(5):362-79. Review. Erratum in: Ann Intern Med. 2005 Oct 4;143(7):547.

PMID:
16144895

Supplemental Content

Support Center